BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen T, Vunjak-Novakovic G. In vitro Models of Ischemia-Reperfusion Injury. Regen Eng Transl Med 2018;4:142-53. [PMID: 30393757 DOI: 10.1007/s40883-018-0056-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Mohamadian M, Parsamanesh N, Chiti H, Sathyapalan T, Sahebkar A. Protective effects of curcumin on ischemia/reperfusion injury. Phytother Res 2022. [PMID: 36123613 DOI: 10.1002/ptr.7620] [Reference Citation Analysis]
2 Liu C, Feng X, Li G, Gokulnath P, Xiao J. Generating 3D human cardiac constructs from pluripotent stem cells. EBioMedicine 2022;76:103813. [PMID: 35093634 DOI: 10.1016/j.ebiom.2022.103813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Teixeira da Silva R, Machado IF, Teodoro JS, Panisello-Roselló A, Roselló-Catafau J, Rolo AP, Palmeira CM. PEG35 as a Preconditioning Agent against Hypoxia/Reoxygenation Injury. Int J Mol Sci 2022;23:1156. [PMID: 35163080 DOI: 10.3390/ijms23031156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wagner KT, Radisic M. A New Role for Extracellular Vesicles in Cardiac Tissue Engineering and Regenerative Medicine. Adv Nanobiomed Res 2021;1:2100047. [PMID: 34927167 DOI: 10.1002/anbr.202100047] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Sivakumar B, Kurian GA. PM2.5 from diesel exhaust attenuated fisetin mediated cytoprotection in H9c2 cardiomyocytes subjected to ischemia reoxygenation by inducing mitotoxicity. Drug Chem Toxicol 2021;:1-9. [PMID: 34806509 DOI: 10.1080/01480545.2021.2003698] [Reference Citation Analysis]
6 Haase K, Piatti F, Marcano M, Shin Y, Visone R, Redaelli A, Rasponi M, Kamm RD. Physiologic flow-conditioning limits vascular dysfunction in engineered human capillaries. Biomaterials 2021;:121248. [PMID: 34794827 DOI: 10.1016/j.biomaterials.2021.121248] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
7 Lindsey ML, de Castro Brás LE, DeLeon-Pennell KY, Frangogiannis NG, Halade GV, O'Meara CC, Spinale FG, Kassiri Z, Kirk JA, Kleinbongard P, Ripplinger CM, Brunt KR. Reperfused vs. nonreperfused myocardial infarction: when to use which model. Am J Physiol Heart Circ Physiol 2021;321:H208-13. [PMID: 34114891 DOI: 10.1152/ajpheart.00234.2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chingale M, Zhu D, Cheng K, Huang K. Bioengineering Technologies for Cardiac Regenerative Medicine. Front Bioeng Biotechnol 2021;9:681705. [PMID: 34150737 DOI: 10.3389/fbioe.2021.681705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
9 Madonna R, Guarnieri S, Kovácsházi C, Görbe A, Giricz Z, Geng YJ, Mariggiò MA, Ferdinandy P, De Caterina R. Telomerase/myocardin expressing mesenchymal cells induce survival and cardiovascular markers in cardiac stromal cells undergoing ischaemia/reperfusion. J Cell Mol Med 2021;25:5381-90. [PMID: 33949765 DOI: 10.1111/jcmm.16549] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Liu Chung Ming C, Sesperez K, Ben-Sefer E, Arpon D, McGrath K, McClements L, Gentile C. Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease. Cells 2021;10:899. [PMID: 33919808 DOI: 10.3390/cells10040899] [Reference Citation Analysis]
11 Häkli M, Kreutzer J, Mäki AJ, Välimäki H, Lappi H, Huhtala H, Kallio P, Aalto-Setälä K, Pekkanen-Mattila M. Human induced pluripotent stem cell-based platform for modeling cardiac ischemia. Sci Rep 2021;11:4153. [PMID: 33603154 DOI: 10.1038/s41598-021-83740-w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 De Lazzari F, Prag HA, Gruszczyk AV, Whitworth AJ, Bisaglia M. DJ-1: A promising therapeutic candidate for ischemia-reperfusion injury. Redox Biol 2021;41:101884. [PMID: 33561740 DOI: 10.1016/j.redox.2021.101884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sharma P, Wang X, Ming CLC, Vettori L, Figtree G, Boyle A, Gentile C. Considerations for the Bioengineering of Advanced Cardiac In Vitro Models of Myocardial Infarction. Small 2021;17:2003765. [DOI: 10.1002/smll.202003765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Shi C, Li G, Guo H, Liu X. Forkhead transcription factor FOXO1 is involved in hypoxia/reoxygenation-induced gonadotropin-releasing hormone decline. Neuroreport 2020;31:1296-301. [PMID: 33165202 DOI: 10.1097/WNR.0000000000001548] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhu Z, Ling X, Zhou H, Zhang C. Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress. Exp Ther Med 2021;21:132. [PMID: 33376514 DOI: 10.3892/etm.2020.9564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Wagner KT, Nash TR, Liu B, Vunjak-Novakovic G, Radisic M. Extracellular Vesicles in Cardiac Regeneration: Potential Applications for Tissues-on-a-Chip. Trends Biotechnol 2021;39:755-73. [PMID: 32958383 DOI: 10.1016/j.tibtech.2020.08.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 Cui H, Liu C, Esworthy T, Huang Y, Yu ZX, Zhou X, San H, Lee SJ, Hann SY, Boehm M, Mohiuddin M, Fisher JP, Zhang LG. 4D physiologically adaptable cardiac patch: A 4-month in vivo study for the treatment of myocardial infarction. Sci Adv 2020;6:eabb5067. [PMID: 32637623 DOI: 10.1126/sciadv.abb5067] [Cited by in Crossref: 27] [Cited by in F6Publishing: 45] [Article Influence: 13.5] [Reference Citation Analysis]
18 Fang J, Wei Z, Zheng D, Ying T, Hong H, Hu D, Lin Y, Jiang X, Wu L, Lan T, Yang Z, Zhou X, Chen L. Recombinant Extracellular Domain (p75ECD) of the Neurotrophin Receptor p75 Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting the p-JNK/Caspase-3 Signaling Pathway in Rat Microvascular Pericytes. J Am Heart Assoc 2020;9:e016047. [PMID: 32567476 DOI: 10.1161/JAHA.119.016047] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Vasanthan V, Fatehi Hassanabad A, Pattar S, Niklewski P, Wagner K, Fedak PWM. Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials. Front Bioeng Biotechnol 2020;8:291. [PMID: 32363184 DOI: 10.3389/fbioe.2020.00291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Golforoush P, Schneider MD. Intensive care for human hearts in pluripotent stem cell models. NPJ Regen Med 2020;5:4. [PMID: 32194989 DOI: 10.1038/s41536-020-0090-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Liu H, Bolonduro OA, Hu N, Ju J, Rao AA, Duffy BM, Huang Z, Black LD, Timko BP. Heart-on-a-Chip Model with Integrated Extra- and Intracellular Bioelectronics for Monitoring Cardiac Electrophysiology under Acute Hypoxia. Nano Lett 2020;20:2585-93. [DOI: 10.1021/acs.nanolett.0c00076] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
22 Jeddi S, Gheibi S, Kashfi K, Carlström M, Ghasemi A. Dose-Dependent Effects of Long-Term Administration of Hydrogen Sulfide on Myocardial Ischemia-Reperfusion Injury in Male Wistar Rats: Modulation of RKIP, NF-κB, and Oxidative Stress. Int J Mol Sci 2020;21:E1415. [PMID: 32093102 DOI: 10.3390/ijms21041415] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
23 Wagner JUG, Pham MD, Nicin L, Hammer M, Bottermann K, Yuan T, Sharma R, John D, Muhly-Reinholz M, Tombor L, Hardt M, Madl J, Dimmeler S, Krishnan J. Dissection of heterocellular cross-talk in vascularized cardiac tissue mimetics. J Mol Cell Cardiol 2020;138:269-82. [PMID: 31866374 DOI: 10.1016/j.yjmcc.2019.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
24 Simon LR, Masters KS. Disease-inspired tissue engineering: Investigation of cardiovascular pathologies. ACS Biomater Sci Eng 2020;6:2518-32. [PMID: 32974421 DOI: 10.1021/acsbiomaterials.9b01067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
25 Fiedler LR, Chapman K, Xie M, Maifoshie E, Jenkins M, Golforoush PA, Bellahcene M, Noseda M, Faust D, Jarvis A, Newton G, Paiva MA, Harada M, Stuckey DJ, Song W, Habib J, Narasimhan P, Aqil R, Sanmugalingam D, Yan R, Pavanello L, Sano M, Wang SC, Sampson RD, Kanayaganam S, Taffet GE, Michael LH, Entman ML, Tan TH, Harding SE, Low CMR, Tralau-Stewart C, Perrior T, Schneider MD. MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo. Cell Stem Cell 2019;24:579-591.e12. [PMID: 30853557 DOI: 10.1016/j.stem.2019.01.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]